Laboratoire GBCM, EA7528, Conservatoire National des Arts et Métiers, 2 Rue Conté, Hésam Université, 75003 Paris, France.
Inserm U1268 MCTR, CNRS UMR 8038 CiTCoM - Univ. de Paris, Faculté de Pharmacie de Paris, 4 av de l'Observatoire, CEDEX 06, 75270 Paris, France.
Int J Mol Sci. 2019 Sep 19;20(18):4648. doi: 10.3390/ijms20184648.
Chemical biology and drug discovery are complex and costly processes. In silico screening approaches play a key role in the identification and optimization of original bioactive molecules and increase the performance of modern chemical biology and drug discovery endeavors. Here, we describe a free web-based protocol dedicated to small-molecule virtual screening that includes three major steps: ADME-Tox filtering (via the web service FAF-Drugs4), docking-based virtual screening (via the web service MTiOpenScreen), and molecular mechanics optimization (via the web service AMMOS2 [Automatic Molecular Mechanics Optimization for in silico Screening]). The online tools FAF-Drugs4, MTiOpenScreen, and AMMOS2 are implemented in the freely accessible RPBS (Ressource Parisienne en Bioinformatique Structurale) platform. The proposed protocol allows users to screen thousands of small molecules and to download the top 1500 docked molecules that can be further processed online. Users can then decide to purchase a small list of compounds for in vitro validation. To demonstrate the potential of this online-based protocol, we performed virtual screening experiments of 4574 approved drugs against three cancer targets. The results were analyzed in the light of published drugs that have already been repositioned on these targets. We show that our protocol is able to identify active drugs within the top-ranked compounds. The web-based protocol is user-friendly and can successfully guide the identification of new promising molecules for chemical biology and drug discovery purposes.
化学生物学和药物发现是复杂且昂贵的过程。计算筛选方法在鉴定和优化原始生物活性分子方面发挥着关键作用,并提高了现代化学生物学和药物发现工作的效率。在这里,我们描述了一种免费的基于网络的小分子虚拟筛选协议,该协议包括三个主要步骤:ADME-Tox 过滤(通过网络服务 FAF-Drugs4)、基于对接的虚拟筛选(通过网络服务 MTiOpenScreen)和分子力学优化(通过网络服务 AMMOS2[用于虚拟筛选的自动分子力学优化])。网络工具 FAF-Drugs4、MTiOpenScreen 和 AMMOS2 都在免费访问的 RPBS(巴黎结构生物信息学资源)平台上实现。所提出的协议允许用户筛选数千种小分子,并下载前 1500 个对接分子,然后可以在线进一步处理。用户可以决定购买一小部分化合物进行体外验证。为了展示这个在线协议的潜力,我们针对三个癌症靶点对 4574 种已批准的药物进行了虚拟筛选实验。根据已在这些靶点上重新定位的已发表药物对结果进行了分析。我们表明,我们的协议能够在排名靠前的化合物中识别出活性药物。该基于网络的协议易于使用,可以成功地指导识别用于化学生物学和药物发现目的的新有前途的分子。